Hinge Health/$HNGE
13:30
03:10
16:45
06:25
20:00
1D1W1MYTD1Y5YMAX
About Hinge Health
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients. The Company's clients are self-insured employers.
Ticker
$HNGE
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
1,514
ISIN
US4333131039
Website
Hinge Health Metrics
BasicAdvanced
$3.1B
9.75
$4.07
-
-
Price and volume
Market cap
$3.1B
52-week high
$43.80
52-week low
$33.42
Financial strength
Current ratio
2.311
Quick ratio
2.044
Long term debt to equity
1.42
Total debt to equity
2.309
Profitability
EBITDA (TTM)
22.371
Gross margin (TTM)
79.46%
Net profit margin (TTM)
7.34%
Operating margin (TTM)
4.67%
Effective tax rate (TTM)
4.57%
Revenue per employee (TTM)
$290,000
Management effectiveness
Valuation
Price to earnings (TTM)
9.752
Price to revenue (TTM)
1.293
Price to book
-2.12
Price to tangible book (TTM)
-1.74
Price to free cash flow (TTM)
6.723
Free cash flow yield (TTM)
14.87%
Free cash flow per share (TTM)
590.98%
Growth
What the Analysts think about Hinge Health
Analyst ratings (Buy, Hold, Sell) for Hinge Health stock.
Bulls say / Bears say
Hinge Health reported a 33% year-over-year revenue increase to $390 million in 2024, demonstrating strong financial growth. (healthitmedia.com)
The company achieved a significant reduction in net losses, from $108 million in 2023 to $11.9 million in 2024, indicating improved financial health. (healthitmedia.com)
Hinge Health's membership grew to 532,326 by the end of 2024, up from 370,526 in 2023, reflecting increasing adoption of its services. (healthitmedia.com)
Despite revenue growth, Hinge Health's valuation has decreased from $6.2 billion in 2021 to a targeted $2.6 billion in its 2025 IPO, indicating potential investor concerns. (reuters.com)
The company laid off about 10% of its workforce in April 2024 to improve operational efficiency, which may signal underlying challenges. (healthitmedia.com)
Hinge Health faces strong competition from companies like Sword Health, which was valued at $3 billion in 2024, potentially impacting market share. (businessinsider.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.
Hinge Health Financial Performance
Revenues and expenses
Hinge Health Earnings Performance
Company profitability
Hinge Health News
AllArticlesVideos
Hinge Health Announces HingeSelect - a High-performance Network Delivering Unified Musculoskeletal Care
Business Wire·5 days ago
Fully insured medical claims analysis shows significant cost savings and 2.4x ROI for Hinge Health populations
Business Wire·2 weeks ago
IPO Stock Of The Week: Hinge Health Eyes First Buy Point
Investors Business Daily·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Hinge Health stock?
Hinge Health (HNGE) has a market cap of $3.1B as of June 20, 2025.
What is the P/E ratio for Hinge Health stock?
The price to earnings (P/E) ratio for Hinge Health (HNGE) stock is 9.75 as of June 20, 2025.
Does Hinge Health stock pay dividends?
No, Hinge Health (HNGE) stock does not pay dividends to its shareholders as of June 20, 2025.
When is the next Hinge Health dividend payment date?
Hinge Health (HNGE) stock does not pay dividends to its shareholders.
What is the beta indicator for Hinge Health?
Hinge Health (HNGE) does not currently have a Beta indicator.
